|
Volumn 106, Issue 5, 2002, Pages 631-636
|
Defining gene transfer before expecting gene therapy putting the horse before the cart
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GENE PRODUCT;
CARDIOVASCULAR DISEASE;
DRUG DELIVERY SYSTEM;
DRUG TRANSFORMATION;
GENE DELIVERY SYSTEM;
GENE THERAPY;
GENE TRANSFER;
HUMAN;
NONHUMAN;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
REVIEW;
TRANSGENE;
BIOTRANSFORMATION;
CARDIOVASCULAR DISEASES;
ENDOTHELIAL GROWTH FACTORS;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
GRAFT OCCLUSION, VASCULAR;
HUMANS;
LYMPHOKINES;
NEOVASCULARIZATION, PHYSIOLOGIC;
PHARMACOKINETICS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0037199399
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000019621.18368.B7 Document Type: Review |
Times cited : (37)
|
References (30)
|